Research Article
Clinical and Autoimmune Profile of Scleroderma Patients from Western India
Table 3
Association of autoantibodies with organ manifestations in SSc patients (
).
| Autoantibodies | Pulmonary | Renal | Musculoskeletal | Gastrointestinal | Cardiovascular |
| ANA () | 65 (69.1%) | 80 (85.1%) | 75 (79.8%) | 52 (55.3%) | 40 (42.6%) | Anti-Scl70 antibodies () | 28 (40.6%) | 40 (58%) | 48 (69.6%) | 10 (14.5%) | 10 (14.5%) | Anti-centromere antibodies () | 18 (72%) | 20 (80%) | 08 (32%) | 08 (32%) | 10 (40%) | Anti-endothelial cell antibodies (AECA) () | 15 (45.5%) | 28 (84.9%) | 14 (42.4%) | 10 (30.3%) | 24 (72.7%) | Anti-keratinocyte antibodies (AKA) () | 20 (44.4%) | 18 (40%) | 10 (22.2%) | 05 (11.1%) | 05 (11.1%) |
|
|